Role of MRI in minimally invasive focal ablative therapy for prostate cancer

American Journal of Roentgenology

Volumn 197, Issue 1, 2011, Pages

  Rosenkrantz, Andrew B ^a   Scionti, Stephen M ^a   Mendrinos, Savvas ^a   Taneja, Samir S ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Ablation; Focal therapy; MRI; Prostate cancer

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ABLATION THERAPY; CANCER RECURRENCE; CRYOABLATION; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; MINIMALLY INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SELECTION; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; REVIEW; TUMOR NECROSIS;

AGED; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROSTATECTOMY; PROSTATIC NEOPLASMS; SURGERY, COMPUTER-ASSISTED;

EID: 79960493262     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.10.5946     Document Type: Review

References (48)

1. American Cancer Society. Cancer facts and figures 2010. Atlanta, GA: American Cancer Society, 2010:10
2. Cooperberg MR, Moul JW, Carroll PR. The changing face of prostate cancer. J Clin Oncol 2005; 23:8146-8151 (Pubitemid 46211547)
3. Bill-Axelson A, Holmberg L, Ruutu M, et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 2005; 352: 1977-1984 (Pubitemid 40638368)
4. Ahmed HU, Emberton M. Is focal therapy the future for prostate cancer? Future Oncol 2010; 6: 261-268
5. Schroder FH, Hugosson J, Roobol MJ, et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 2009; 360:1320-1328
6. Sanda MG, Dunn RL, Michalski J, et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med 2008; 358: 1250-1261 (Pubitemid 351439226)
7. Hu JC, Gu X, Lipsitz SR, et al. Comparative effectiveness of minimally invasive vs open radical prostatectomy. JAMA 2009; 302:1557-1564
8. Ahmed HU, Pendse D, Illing R, Allen C, van der Meulen JH, Emberton M. Will focal therapy become a standard of care for men with localized prostate cancer? Nat Clin Pract Oncol 2007; 4:632-642 (Pubitemid 350020378)
9. Jamal K, Patel P, Sooriakumaran P. Minimally invasive surgical modalities in the management of localized prostate cancer. Expert Rev Anticancer Ther 2008; 8:957-966
10. Marberger M. Energy-based ablative therapy of prostate cancer: high-intensity focused ultrasound and cryoablation. Curr Opin Urol 2007; 17:194-199 (Pubitemid 46597440)
11. Lecornet E, Ahmed HU, Moore CM, Emberton M. Conceptual basis for focal therapy in prostate cancer. J Endourol 2010; 24:811-818
12. Onik G. Percutaneous image-guided prostate cancer treatment: cryoablation as a successful example. Tech Vasc Interv Radiol 2007; 10:149-158 (Pubitemid 350216514)
13. Pisters LL. Cryotherapy for prostate cancer: ready for prime time? Curr Opin Urol 2010; 20:218-222
14. Choi YJ, Kim JK, Kim N, Kim KW, Choi EK, Cho KS. Functional MR imaging of prostate cancer. RadioGraphics 2007; 27:63-75; discussion, 75-77
15. Turkbey B, Albert PS, Kurdziel K, Choyke PL. Imaging localized prostate cancer: current approaches and new developments. AJR 2009; 192: 1471-1480
16. Meiers I, Waters DJ, Bostwick DG. Preoperative prediction of multifocal prostate cancer and application of focal therapy: review 2007. Urology 2007; 70(6 suppl):3-8
17. Nogueira L, Wang L, Fine SW, et al. Focal treatment or observation of prostate cancer: pretreatment accuracy of transrectal ultrasound biopsy and T2-weighted MRI. Urology 2010; 75:472-477
18. Turkbey B, Pinto PA, Mani H, et al. Prostate cancer: value of multiparametric MR imaging at 3 T for detection - histopathologic correlation. Radiology 2010; 255:89-99
19. Mayes JM, Mouraviev V, Sun L, Tsivian M, Madden JF, Polascik TJ. Can the conventional sextant prostate biopsy accurately predict unilateral prostate cancer in low-risk, localized, prostate cancer? Urol Oncol 2011; 29:166-170
20. Barzell WE, Melamed MR. Appropriate patient selection in the focal treatment of prostate cancer: the role of transperineal 3-dimensional pathologic mapping of the prostate - a 4-year experience. Urology 2007; 70(6 suppl):27-35
21. Onik G, Miessau M, Bostwick DG. Three-dimensional prostate mapping biopsy has a potentially significant impact on prostate cancer management. J Clin Oncol 2009; 27:4321-4326
22. Mouraviev V, Mayes JM, Madden JF, Sun L, Polascik TJ. Analysis of laterality and percentage of tumor involvement in 1386 prostatectomized specimens for selection of unilateral focal cryotherapy. Technol Cancer Res Treat 2007; 6:91-95 (Pubitemid 46668716)
23. Mouraviev V, Mayes JM, Sun L, Madden JF, Moul JW, Polascik TJ. Prostate cancer laterality as a rationale of focal ablative therapy for the treatment of clinically localized prostate cancer. Cancer 2007; 110:906-910 (Pubitemid 47257670)
24. Ahmed HU. The index lesion and the origin of prostate cancer. N Engl J Med 2009; 361:1704-1706
25. Bott SR, Ahmed HU, Hindley RG, Abdul-Rahman A, Freeman A, Emberton M. The index lesion and focal therapy: an analysis of the pathological characteristics of prostate cancer. BJU Int 2010; 106:1607-1611
26. Karavitakis M, Winkler M, Abel P, Livni N, Beckley I, Ahmed HU. Histological characteristics of the index lesion in whole-mount radical prostatectomy specimens: implications for focal therapy. Prostate Cancer Prostatic Dis 2011; 14:46-52
27. Rukstalis DB, Goldknopf JL, Crowley EM, Garcia FU. Prostate cryoablation: a scientific rationale for future modifications. Urology 2002; 60:19-25 (Pubitemid 36153110)
28. Langer DL, van der Kwast TH, Evans AJ, et al. Intermixed normal tissue within prostate cancer: effect on MR imaging measurements of apparent diffusion coefficient and T2 - sparse versus dense cancers. Radiology 2008; 249:900-908
29. Rieke V, Kinsey AM, Ross AB, et al. Reference-less MR thermometry for monitoring thermal ablation in the prostate. IEEE Trans Med Imaging 2007; 26:813-821 (Pubitemid 46842916)
30. Samset E. Temperature mapping of thermal ablation using MRI. Minim Invasive Ther Allied Technol 2006; 15:36-41 (Pubitemid 43203357)
31. Fennessy FM, Tuncali K, Morrison PR, Tempany CM. MR imaging-guided interventions in the genitourinary tract: an evolving concept. Radiol Clin North Am 2008; 46:149-166, vii
32. D'Amico AV, Cormack R, Tempany CM, et al. Real-time magnetic resonance image-guided interstitial brachytherapy in the treatment of select patients with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 1998; 42:507-515 (Pubitemid 28501098)
33. Hurwitz MD, Cormack R, Tempany CM, Kumar S, D'Amico AV. Three-dimensional real-time magnetic resonance-guided interstitial prostate brachytherapy optimizes radiation dose distribution resulting in a favorable acute side effect profile in patients with clinically localized prostate cancer. Tech Urol 2000; 6:89-94 (Pubitemid 30227181)
34. Diederich CJ, Nau WH, Ross AB, et al. Catheter-based ultrasound applicators for selective thermal ablation: progress towards MRI-guided applications in prostate. Int J Hyperthermia 2004; 20:739-756 (Pubitemid 39516858)
35. Sokka SD, Hynynen KH. The feasibility of MRIguided whole prostate ablation with a linear aperiodic intracavitary ultrasound phased array. Phys Med Biol 2000; 45:3373-3383
36. Pauly KB, Diederich CJ, Rieke V, et al. Magnetic resonance-guided high-intensity ultrasound ablation of the prostate. Top Magn Reson Imaging 2006; 17:195-207 (Pubitemid 46586212)
37. Smith NB, Buchanan MT, Hynynen K. Transrectal ultrasound applicator for prostate heating monitored using MRI thermometry. Int J Radiat Oncol Biol Phys 1999; 43:217-225 (Pubitemid 29065847)
38. Raz O, Haider MA, Davidson SR, et al. Real-time magnetic resonance imaging-guided focal laser therapy in patients with low-risk prostate cancer. Eur Urol 2010; 58:173-177
39. Haider MA, Davidson SR, Kale AV, et al. Prostate gland: MR imaging appearance after vascular targeted photodynamic therapy with palladium-bacteriopheophorbide. Radiology 2007; 244:196-204 (Pubitemid 46981974)
40. Donnelly SE, Donnelly BJ, Saliken JC, Raber EL, Vellet AD. Prostate cancer: gadolinium-enhanced MR imaging at 3 weeks compared with needle biopsy at 6 months after cryoablation. Radiology 2004; 232:830-833 (Pubitemid 39100270)
41. Kalbhen CL, Hricak H, Shinohara K, et al. Prostate carcinoma: MR imaging findings after cryosurgery. Radiology 1996; 198:807-811
42. Kirkham AP, Emberton M, Hoh IM, Illing RO, Freeman AA, Allen C. MR imaging of prostate after treatment with high-intensity focused ultrasound. Radiology 2008; 246:833-844
43. Boni RA, Sulser T, Jochum W, Romanowski B, Debatin JF, Krestin GP. Laser ablation-induced changes in the prostate: findings at endorectal MR imaging with histologic correlation. Radiology 1997; 202:232-236 (Pubitemid 27024132)
44. Vellet AD, Saliken J, Donnelly B, et al. Prostatic cryosurgery: use of MR imaging in evaluation of success and technical modifications. Radiology 1997; 203:653-659 (Pubitemid 27227410)
45. Rouviere O, Lyonnet D, Raudrant A, et al. MRI appearance of prostate following transrectal HIFU ablation of localized cancer. Eur Urol 2001; 40:265-274 (Pubitemid 34701896)
46. Kim CK, Park BK, Lee HM, Kim SS, Kim E. MRI techniques for prediction of local tumor progression after high-intensity focused ultrasonic ablation of prostate cancer. AJR 2008; 190:1180-1186 (Pubitemid 351684917)
47. Rouviere O, Girouin N, Glas L, et al. Prostate cancer transrectal HIFU ablation: detection of local recurrences using T2-weighted and dynamic contrast-enhanced MRI. Eur Radiol 2010; 20:48-55
48. Rouviere O, Vitry T, Lyonnet D. Imaging of prostate cancer local recurrences: why and how? Eur Radiol 2010; 20:1254-1266